Results 211 to 220 of about 98,806 (295)

Decoding the human tongue of light chain amyloidosis in three dimensions (3D): three-dimensional pathological visualization drives early and precise screening of suspected cases. [PDF]

BMC Oral Health
Wu L, Sun F, Xu S, Gao X, Chen J, Zhang Z, Liu Z, Qu Y, Wang Z.   +8 more
europepmc   +1 more source

Amyloid a Protein Amyloidosis in a Patient with Plasma Cell Dyscrasia.

, 2002
Hiroki Ishikawa, Keisuke Nakata, Tomoyuki Aritomi, Kazuaki Ohkubo, Kiyoshi Migita, Keisuke Hamasaki, Satoshi Yamasaki, Kazuhiko Nakao, Yuji Kato, Tomayoshi Hayashi, Katsumi Eguchi   +10 more
openalex   +1 more source

Sural/Radial Amplitude Ratio: A Useful Tool to Diagnose Non‐Length‐Dependent Neuropathy

Muscle &Nerve, Volume 73, Issue 1, Page 34-40, January 2026.
ABSTRACT Introduction/Aims Patients with non‐length‐dependent neuropathy (NLDN) exhibit reduced sensory nerve action potential (SNAP) amplitudes in both lower and upper limbs. This study aimed to determine a threshold for the sural/radial amplitude ratio (SRAR) suggestive of NLDN.
Antoine Pegat, Antoine Gavoille, Florent Cluse, Martin Moussy, Philippe Petiot, Jean‐Philippe Camdessanché, Françoise Bouhour   +6 more
wiley   +1 more source

Identifying the quantity profiles of amyloid signature proteins in different types of renal amyloidosis. [PDF]

BMC Nephrol
Wang S, Li D, Zhang X, Zhou F, Wang S.
europepmc   +1 more source

Clinical Utility of Serum Neurofilament Light Chain in Peripheral Neuropathy

Muscle &Nerve, Volume 73, Issue 1, Page 86-92, January 2026.
ABSTRACT Introductions/Aims The clinical utility of serum neurofilament light chain (sNfL) in the evaluation and management of peripheral neuropathy (PN) remains poorly defined. This study aimed to evaluate the utility of sNfL for diagnosing PN, assessing disease activity, and monitoring treatment response using a commercially available assay.
Chafic Karam
wiley   +1 more source

Longitudinal MRI Characterization of T1 and T2 Relaxation Times in an Amyloid Mouse Model of Alzheimer's Disease at 11.7 T

NMR in Biomedicine, Volume 39, Issue 1, January 2026.
In this study, we systematically characterized the longitudinal evolution of T1 and T2 relaxation times at the early to middle stage of Tg2576 mouse model representing the amyloidosis subtype of Alzheimer’s disease. We found that rates of change in relaxation times within the thalamus, hypothalamus, and piriform cortex may serve as markers for ...
Soven Kumar, Xiuli Yang, Yuguo Li, Adnan Bibic, Zhiliang Wei   +4 more
wiley   +1 more source

Co-Existing ATTR Amyloidosis and Coronary Artery Disease: A Risky Combination. [PDF]

Clin Case Rep
Planchat A, Guijarro D, Musayeb Y, Giannakopoulos G, Giraud R, Poku NK, Py DA, Noble S.   +7 more
europepmc   +1 more source

Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health

Journal of Internal Medicine, Volume 299, Issue 1, Page 20-43, January 2026.
Abstract Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline. Although amyloid‐β and tau pathologies remain central to our understanding of AD, growing evidence suggests that disrupted lipid metabolism and impaired bioenergetics are closely linked to these hallmark features. Genetic, lipidomic
Silvia Maioli, Ivan Nalvarte, Maria Ankarcrona, Marianne Schultzberg, Kristen L. Zuloaga, Julen Goikolea, Pieter Jelle Visser, Bart De Strooper, Bengt Winblad, Paola Pizzo, Pete A. Williams, Patricia Rodriguez‐Rodriguez, Luana Naia   +12 more
wiley   +1 more source

Correction: New insights into the molecular biology of Alzheimer's-like cerebral amyloidosis achieved through multi-omics approaches. [PDF]

PLoS One
Campanelli L, Sendoya JM, Brody S, Galeano P, Do Carmo S, Cuello AC, Castaño EM, Gonzalés-Jimenez A, Verheul-Campos J, Medina-Vera D, de Fonseca FR, Wernersson R, Morelli L.   +12 more
europepmc   +1 more source

Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large‐scale analysis of genetic predisposition and disease subtypes

Journal of Internal Medicine, Volume 299, Issue 1, Page 95-108, January 2026.
Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a heterogenous clinical picture. This study aimed to link genetic SLE predisposition with relevant clinical manifestations. Method Datasets best corresponding to the 11 American College of Rheumatology 1982 (ACR‐82) classification criteria for SLE in a large, public ...
Sarah Reid, Johanna K. Sandling, Pascal Pucholt, Ahmed Sayadi, Martina Frodlund, Karoline Lerang, Iva Gunnarsson, Andreas Jönsen, Ann‐Christine Syvänen, Øyvind Molberg, Solbritt Rantapää‐Dahlqvist, Anna Rudin, Christopher Sjöwall, Elisabet Svenungsson, Anders A. Bengtsson, Lars Rönnblom, Dag Leonard   +16 more
wiley   +1 more source